Tandem Diabetes Care Inc (NASDAQ: TNDM) on Friday, soared 7.94% from the previous trading day, before settling in for the closing price of $33.27. Within the past 52 weeks, TNDM’s price has moved between $21.85 and $53.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 36.59% over the last five years. The company achieved an average annual earnings per share of 50.60%. With a float of $65.20 million, this company’s outstanding shares have now reached $65.65 million.
The firm has a total of 2400 workers. Let’s measure their productivity. In terms of profitability, gross margin is 43.69%, operating margin of -13.72%, and the pretax margin is -12.65%.
Tandem Diabetes Care Inc (TNDM) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Tandem Diabetes Care Inc is 0.72%, while institutional ownership is 112.78%. The most recent insider transaction that took place on Nov 21 ’24, was worth 941,400. In this transaction Director of this company sold 30,000 shares at a rate of $31.38, taking the stock ownership to the 165,190 shares. Before that another transaction happened on Nov 20 ’24, when Company’s Director sold 10,000 for $30.00, making the entire transaction worth $300,000. This insider now owns 195,190 shares in total.
Tandem Diabetes Care Inc (TNDM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.60% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 38.80% during the next five years compared to -6.11% drop over the previous five years of trading.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Trading Performance Indicators
Tandem Diabetes Care Inc (TNDM) is currently performing well based on its current performance indicators. A quick ratio of 2.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.94, a number that is poised to hit -0.21 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Tandem Diabetes Care Inc (TNDM)
Analysing the last 5-days average volume posted by the [Tandem Diabetes Care Inc, TNDM], we can find that recorded value of 1.72 million was better than the volume posted last year of 1.59 million. As of the previous 9 days, the stock’s Stochastic %D was 71.42%. Additionally, its Average True Range was 1.88.
During the past 100 days, Tandem Diabetes Care Inc’s (TNDM) raw stochastic average was set at 42.84%, which indicates a significant decrease from 94.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.61% in the past 14 days, which was lower than the 66.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $32.45, while its 200-day Moving Average is $38.76. Now, the first resistance to watch is $37.32. This is followed by the second major resistance level at $38.74. The third major resistance level sits at $41.17. If the price goes on to break the first support level at $33.48, it is likely to go to the next support level at $31.05. Now, if the price goes above the second support level, the third support stands at $29.63.
Tandem Diabetes Care Inc (NASDAQ: TNDM) Key Stats
Market capitalization of the company is 2.55 billion based on 65,677K outstanding shares. Right now, sales total 747,720 K and income totals -222,610 K. The company made 243,970 K in profit during its latest quarter, and -23,250 K in sales during its previous quarter.
